Viewing Study NCT04703192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-02-04 @ 12:54 PM
Study NCT ID: NCT04703192
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2021-01-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
Sponsor: Daiichi Sankyo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Peripheral T-Cell Lymphoma View
None Adult T Cell Leukemia/Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed/Refractory Peripheral T-Cell Lymphoma View
None Adult T-Cell Leukemia/Lymphoma View
None Valemetostat Tosylate View
None DS-3201b View